- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 333.93M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $188.05M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $208.09M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $122.69M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $122.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $198.88M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $200.02M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $512.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $457.02M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $966.74M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $910.43M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $115.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $134.19M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 266.22K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $4.17M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$122.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $680.02M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $584.61M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.42 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.42 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $31.39M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $79.78M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$112.98M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$117.72M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $7.26M |
| Revenue | Q1 2025 · Mar 31, 2024 | $715K |